Cadila Healthcare Ahmedabad facility gets EIR from USFDA Medical Dialogues Bureau11 Feb 2020 6:39 AM The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying...
Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore Farhat Nasim9 Feb 2020 5:00 AM "The company has entered into the definitive agreements (share subscription and share purchase agreement and shareholders agreement)...with Kedaara...
Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore Medical Dialogues Bureau1 Feb 2020 4:15 AM Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
Japanese financial group MUFG sells 2.10pc shares in Cipla Medical Dialogues Bureau23 Jan 2020 4:30 AM "MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First...
IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection Medical Dialogues Bureau30 Oct 2019 8:41 AMMumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs Medical Dialogues Bureau28 Oct 2019 4:15 AMThe administrative committee of the board approved the issue of secured NCDs on private placement basis up to Rs 500 crore with an option to retain...
Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia Medical Dialogues Bureau25 Oct 2019 6:02 AMHaloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
Dr Reddys recalls Ranitidine products in US over cancer-causing impurity Medical Dialogues Bureau24 Oct 2019 4:00 AMThis recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 4:30 AM"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility Medical Dialogues Bureau11 Oct 2019 3:45 AMTorrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
Aurobindo Pharma Unit-7 gets 7 USFDA observations Medical Dialogues Bureau8 Oct 2019 9:24 AMThe United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 6:30 AMOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
